GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (FRA:5TX) » Definitions » Valuation Rank

Sensus Healthcare (FRA:5TX) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Sensus Healthcare Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sensus Healthcare Valuation Rank Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensus Healthcare (FRA:5TX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (FRA:5TX) » Definitions » Valuation Rank
Comparable Companies
ECOR ICCM ICAD RPID CODX RWLK BSGM PAVM MYO UTRS ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
SRTS:USA
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Website
https://www.sensushealthcare.com
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.